The stock market flirts with breaking out into all-time highs at the same time that claims of unemployment insurance continue to decrease. But it is not all. berries and roses. many favorite indicators are shooting warning signals that the current market is in for quite a storm based on the price of the market in comparison to the actual Gdp of the economy.

Famed investor Warren Buffett decided to dump shares of banks like Goldman Sachs and Wells Fargo and bought into Gold, a sector he once said had no utility whatsoever and is nothing but a magical medal. But with all of this on our chests, many people from around the world have come back here to ask just one, just one simple question. They've traveled far, they've traveled wide, they've spoken truth, and they've spoken lies. But the one thing they all can agree on is that they need to have one simple question answer.

and that question is what. Just What? Charlie Are The top three stocks for this week? Well, in this video, you were going to be learning about the top three stocks for this week. But folks, the stock market ain't no rodeo. You can't just randomly write these stocks and expect to make money.

Trust me when I say that as traders, we're not stock market cowboys. You need to have a clear plan. So let's go ahead and review last week's picks to give you an example. So we called out D-dog last Sunday.

D-dog had gotten beaten down on earnings, recovered and then sold off again, but the earnings announced were actually fairly good. It's just that people had pre-factored in a blowout earnings report, and even though it pretty much had that besides a little bit slender guidance, people still decided to take profits and this led to more selling off and a huge overreaction beatdown. We made the case back then that every reaction is an overreaction, and thus we'd want to trade the overreacting correction. D-dog ended up staying in a pretty consistent range for the beginning of the week, but then on Thursday we got our overreaction correction.

Next, we talked about Eton. Lovely Eton. We originally called Eton out when it was trading at 6 16 and then reiterated it on Sunday around seven dollars. This was because it was due for an Fda approval and then upon pre-market open it pre-anticipatory ran to 10-2 But you're not going to be catching most of this move because the volume is too low.

But throughout the next couple days we had several periods of intense run, but this play was not for the faint of heart. Not only were these runs extremely aggressive, but the Fda didn't even meet the target date for approval. And that's the reality of trading these Fda plays. The reason that you see all of these big runs is because people were anticipating an approval and then it just kept not coming out.

Okay, Next we talked about Baba Baba Goshipa Baba. We talked about how Baba had sold off on U.s China tensions and had an upcoming earnings date The next week we talked about how we wanted baba to find the bottom and then start running up in pre-anticipation of earnings. The next day it declared a bottom at 246 and then ran up to 257. Though this was a week-long run, this was largely a day trading opportunity as most of the clean runs were concentrated intraday like this one hither.

But anyways, folks, somebody wrote me a strongly worded email the other day and they wrote this huge like four paragraph essay in my email and they said something along the lines of Charlie I wish you wouldn't make these videos anymore because you just encourage people to target fast money. Why Charlie, would you want traders to target fast money? The funny thing is that I actually hear this quite a lot. But the thing is that trading is some of the slowest fast money that you'll ever make if you take just one of our previous plays, for example, Trvn, which we covered a few weeks ago. By the way, Trvn was a play that ran up massively on an Fda approval over 100 percent.

Now, if you had taken some of this move, many would say oh well, that's fast money but that's just not true. There's nothing fast money about this. In order to take this move first, have needed to know when Fda approval was actually coming out. You'd then have to do some research into said Fda approval weeks in advance.

You then need to have an actual execution plan for it when it does come out, and you'd have to have an exit plan that allows you to manage your risk of downside but not overly limit your upside. And honestly, you'd likely have also needed at least a few years of experience in order to really trade this play properly. And that's just considering this one winning trade. It doesn't factor in all of the ones that didn't actually pan out or the ones that you got into a setup and then you lost money on.

So again, trading may seem like fast money, but it is some of the slowest fast money that you'll ever make. But anyways, folks, the one thing that is fast and never slow is that hitting of that ravishing like button and that's the only thing that I ask of you in return for this ravishing video and quick plug. For folks who are looking to learn how to trade, we are still offering 50 off Zip Trader You for folks who type in coupon code stay home 2020 before checkout. Now, while I don't think that everybody needs a course, so many people try conflicting trading techniques and try just dabbling in a bunch of different trading styles, but they never really commit to one way of doing something and so they never really get anywhere because they don't have a clear pathway and that's what Ziptrader use solves in a nutshell, but takes some time to ensure that we are indeed a good fit for you.

We have a complete breakdown of Ziptraderu on Ziptraderu.com You can click the link in the description below. Okay, so to start Tcda. Now, Tcda will be having their Fda approval decision on August 22nd for their drug for chronic Kidney Disease. They had this whole fiasco where they were originally slated to be approved here, but that didn't happen as the Fda delayed and made a statement saying that they had deficiencies in their labeling and there were concerns over whether or not it fits regulations as to what can be stated and can't be stated about this drug in the marketing that eventually comes out for it.

This freaked investors out and the stock dove about 50. It bends down to bottom at 12.91 and in this month's top Penny Stocks video, we called it out for a pre-anticipatory run to the approval decision. It's ran up about a dollar since then, but whatever. the goal now is to trade any further pre-anticipatory setup.

Here is the thing. if Tcda was valued at this price Hither when investors were fighting back and forth as to whether an approval would even be given, imagine how an actual reversal would affect the stock price. If this was the reaction to not having a approval, what would be the reaction to having an approval? But remember folks, approvals are never guaranteed and really, we don't need an approval, we just need action to trade off of. And with investors speculating on the chance of approval and with the fact that Tcda is beat down so much, this is ripe for a pre-anticipatory run.

But Charlie, what What are the monkeys saying? Well, here is a chart of where our monkey analyst friends are ranking Tcda. We can see here that even at April lows, they were ranking it in the low 20s. Now, even after all the bad news, the average price target is double that at 42 and Tcda's current trading price is all the way down at 14. So this is a stock whose share price has gotten beaten down massively since April.

While at the same time, analyst price expectations have more than doubled. So here we have an ever increasing price expectation and ever decreasing share price. And to tie everything together, you have a huge catalyst coming up. But of course, the perfect storm doesn't always guarantee a perfect opportunity.

So having a plan and controlling your risk is of utmost importance. By the way, if you are struggling to keep up to date with our plays, well, we do offer nightly watch lists in the Zip Trader Circle Facebook group which you can go and join for free just by clicking the link in the description below. It's a beautiful Facebook Circle folks Zip Trader Circle. Oh, if it is hot today I didn't know ravishiness could be this hot Okay, next, gold.

This is a golden opportunity. Now many of you know that I've had a huge focus on trading gold the last couple of months, and this is one of the biggest opportunities that many of you are just totally ignoring. We reiterated trading it again and again throughout this uptrend. The reason is because gold has tended to go up as the dollar went down, and thus this was a great opportunity as the dollar weakened with huge amounts of money printing and forward-looking uncertainty.

But as the dollar rebounded recently, gold ticked down massively. This is why we trade both sides of gold with Jnug for upswings and Jdst for downswings. Jdst allows us to bet against gold and make money when gold goes down. But anyways, my update on gold is that this recent sell-off has meant that we are now at a price point with lots of upside just to get back to where we were trading at a week or so ago.

And it is humorous to see the monkey analysts eat themselves up over this Back at the end of July, Goldman Sachs put out a release saying that gold and gold derivatives and gold mining indices have no role in the portfolio of their clients. Yet just a few weeks later, the analyst's favorite maverick, Warren Buffett, decided to buy into gold a gold miner stock after this recent dip. So I guess gold isn't good enough for wealthy investors, but it is good enough for one of the most renowned investors of all time. But not only did Warren Buffett disagree with Goldman Sachs analyst's opinion on gold, well, he also decided to dump his entire stake in Goldman Sachs.

Ouch. Okay, but anyways, the way that we trade gold again is through the gold miners indices. J-nugg goes up when gold goes up, and Jdst goes up when gold goes down. That way, we can trade both sides of gold and still come out ahead.

Okay, next Ayx. Now, Ayx ran way past its pre-crisis high and then on the sixth, got beat down like a rabid dog. It then found some level of bottom right down here at around 107 a share. But here is the thing.

Ayx got beat down 40 on earnings. So you must be thinking, wow, those earnings must have been a disaster. Well, you'd mostly be wrong. See, Ayx beat expectations on both revenue and earnings.

But remember, earnings reports are not just reviews of the previous quarter, but they are also a forecast of guidance for the next one. And this is where Ayx spooked investors. They said that while their company would still grow in the rest of 2020, it'll grow at a much slower pace than it did before. This is basically a mixed earnings report.

That said, oh well, we did great last quarter and we are still going to be doing great next quarter, but we're not going to be doing quite as great as the last quarter. We saw the same thing happen with D-dog earlier this week, which is another software as a service company. They beat expectations for the previous quarter, but their next quarter outlook was slower. This had caused a huge beat down, but then a run up over reaction correction which was nearly 50 percent of that beat down.

But granted, Ayx did show a lot more dramatic of a drop, but the fact is that it is showing some early signs of bottoming and does have an insane amount of upward potential even if we were to recover just half of this drop, which makes me excited to play this if we start seeing some signs of price strength. Okay, quick bonus Review: Lpcn Now Lbcn will be having their Fda approval decision on August 28th. We actually called out Lpcn back earlier this month in the top Penny Stock video for August and they've had quite an anticipatory run, and I just wanted to go ahead and take this time. To reiterate it, the fact that pre-anticipatory runs don't have to last all the way to approval.

Sure, it does look like we'll have more opportunity to trade off more pre-anticipatory running, but hey, if it cools off, that's fine too. That gives us more upside if this does eventually get approved, so just make sure that you are trading the fluctuations themselves instead of just randomly buying and holding. Okay folks, Well, I do hope this video was valuable to you. If you have any questions whatsoever, feel free to reach out to us in the comment section below or join us on our lovely Zip Trader Circle.

On Zip Trader Circle, we also post our nightly watch lists and we have a ton of other great stuff on there. So if you are dedicated to trading, go ahead and join us on Zip Trader Circle. And lastly, if you're wondering what broker to trade these stocks on, We always like to send new traders over to Weeble, and Weeble is offering two free stocks if you sign up with our link below. Anyways, folks, have a great day and I'll see you in the next video.